latest news releases from the newsroom
Entropic Communications' Advanced Silicon Tuner Deployed in EchoStar's Over-the-Air Module
SAN DIEGO, July 21, 2009 (GLOBE NEWSWIRE) -- Entropic Communications, Inc. (Nasdaq:ENTR), a leading provider of silicon and software solutions to enable connected home entertainment, announced today that its RF4400 ATSC Silicon Tuner has been selected by EchoStar Technologies L.L.C., a wholly owned subsidiary of EchoStar Corporation (Nasdaq:SATS), for inclusion in its high-definition over-the-air (OTA) module for select HD set-top boxes. The RF4400 is an advanced silicon tuner that provides high performance in a small form factor.
Photo Release -- Jazz Semiconductor and Entropic Communications Announce Volume Production for Multi-Mode Hybrid Silicon Tuner
NEWPORT BEACH, Calif. and SAN DIEGO, July 21, 2009 (GLOBE NEWSWIRE) -- Jazz Semiconductor(r), a Tower Group Company (Nasdaq:TSEM) (TASE:TSEM), and the leader in Analog-Intensive Mixed-Signal (AIMS) foundry solutions, and Entropic Communications, Inc. (Nasdaq:ENTR), a leading provider of silicon & software solutions to enable connected home entertainment, today announced volume production of Entropic's EN4020, the company's new multi-mode hybrid silicon tuner. The EN4020 uses Jazz's cost-effective 0.18-micron CMOS process (CA18QD) and its world class RF modeling design kit to develop small yet effective inductors essential for silicon tuner products. The EN4020 multi-mode silicon tuner supports worldwide standards and is targeted at high volume can tuners as well as high performance digital TV (DTV) and cable/terrestrial set-top box (STB) products.
Protea Biosciences, Inc.
Protea Announces Exclusive License Agreement With Johns Hopkins University; Collaboration Will Focus On the Development of New Protein Tests for Cardiovascular Disease
MORGANTOWN, W.Va., July 21, 2009 (GLOBE NEWSWIRE) -- Protea Biosciences announced today that it has entered into an exclusive license agreement with Johns Hopkins University (JHU) for technology developed in the laboratory of Jennifer Van Eyk, PhD., Professor of Medicine, the Division of Cardiology, Biological Chemistry and Biomedical Engineering. Van Eyk's laboratory team has discovered that proteins bound to human serum albumin, as well as the albumin molecule itself, can yield important new data for improving cardiovascular disease diagnosis and management.
Symyx Technologies, Inc.
Photo Release -- Symyx Screening Pressure Reactor Wins 2009 R&D 100 Award
SUNNYVALE, Calif., July 21, 2009 (GLOBE NEWSWIRE) -- Symyx Technologies, Inc. (Nasdaq:SMMX) today announced that the Symyx Screening Pressure Reactor (SPR) has won an R&D 100 Award for being one of the most technologically significant products introduced into the marketplace in 2009. Selected by an independent judging panel and the editors of R&D Magazine, this award provides a mark of excellence known to industry, government, and academia as proof that the SPR is one of the most innovative products of the year.